Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Facilitating Optimal Outcomes for the Management of Retinal Diseases:Health Plan Best Practice RecommendationsManaged Care Pathway for Better Management of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

January 3, 2023

EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA, Matt White, JD

← Spotlight on Diabetic Retinopathy & Diabetic Macular Edema   Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations: Managed Care Pathway for Better Management of Age-related Macular Degeneration (AMD) →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources
Home
Close
NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now

Return to Top